Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979;7(Suppl 2):255S–260S. doi: 10.1111/j.1365-2125.1979.tb04698.x

Regression of left ventricular hypertrophy during treatment with antihypertensive agents

Lawford S Hill, Mark Monaghan, P J Richardson
PMCID: PMC1429326  PMID: 37879

Abstract

1 Echocardiography showed 14 of 24 patients with essential hypertension to have hypertrophy of their left ventricular walls. In eight of these 14 patients the left ventricular configuration initially fulfilled the criteria for asymmetric septal hypertrophy (ASH) and six were symmetrically hypertrophied, the remaining ten being normal.

2 Following 12 weeks' treatment of hypertension with the object of reducing the supine BP to 150/90 mmHg or below, there was a reduction of wall thickness so that only two of the eight continued to show ASH.

3 The six patients with symmetrical left ventricular hypertrophy also showed a significant reduction in the thickness of the septum and the posterior wall. Those with normal echocardiograms did not change.

4 This reduction of wall thickness produced by antihypertensive therapy may represent regression of left ventricular hypertrophy.

Full text

PDF
255S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berglund G., Sannerstedt R., Andersson O., Wedel H., Wilhelmsen L., Hansson L., Sivertsson R., Wikstrand J. Coronary heart-disease after treatment of hypertension. Lancet. 1978 Jan 7;1(8054):1–5. doi: 10.1016/s0140-6736(78)90356-2. [DOI] [PubMed] [Google Scholar]
  2. Clark C. E., Henry W. L., Epstein S. E. Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med. 1973 Oct 4;289(14):709–714. doi: 10.1056/NEJM197310042891402. [DOI] [PubMed] [Google Scholar]
  3. Hamby R. I., Roberts G. S., Meron J. M. Hypertension and hypertrophic subaortic stenosis. Am J Med. 1971 Oct;51(4):474–481. doi: 10.1016/0002-9343(71)90253-1. [DOI] [PubMed] [Google Scholar]
  4. Henry W. L., Clark C. E., Epstein S. E. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation. 1973 Feb;47(2):225–233. doi: 10.1161/01.cir.47.2.225. [DOI] [PubMed] [Google Scholar]
  5. Karlinger J. S., Williams D., Gorwit J., Crawford M. H., O'Rourke R. A. Left ventricular performance in patients with left ventricular hypertrophy caused by systemic arterial hypertension. Br Heart J. 1977 Nov;39(11):1239–1245. doi: 10.1136/hrt.39.11.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Moreyra E., Knibbe P., Brest A. N. Hypertension and muscular subaortic stenosis. Chest. 1970 Jan;57(1):87–90. doi: 10.1378/chest.57.1.87. [DOI] [PubMed] [Google Scholar]
  7. Sen S., Tarazi R. C., Bumpus F. M. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res. 1977 Sep;11(5):427–433. doi: 10.1093/cvr/11.5.427. [DOI] [PubMed] [Google Scholar]
  8. Toshima H., Koga Y., Yoshioka H., Akiyoshi T., Kimura N. Echocardiographic classification of hypertensive heart disease. A correlative study with clinical features. Jpn Heart J. 1975 Jul;16(4):377–393. doi: 10.1536/ihj.16.377. [DOI] [PubMed] [Google Scholar]
  9. Traill T. A., Gibson D. G., Brown D. J. Study of left ventricular wall thickness and dimension changes using echocardiography. Br Heart J. 1978 Feb;40(2):162–169. doi: 10.1136/hrt.40.2.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Troy B. L., Pombo J., Rackley C. E. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972 Mar;45(3):602–611. doi: 10.1161/01.cir.45.3.602. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES